China Offers Playground Of Opportunity For Trying Out Different Models, Risks - Shanghai R&D Summit
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The rapid transformation of China's pharmaceutical and biotech sector reveals the changing face of this nation and the realization that China is more dynamic than developed markets such as the U.S. and Europe and is a good place to try out different models and approaches to R&D, presenters at the China R&D Summit told attendees April 7